Full Breakdown
Surge in Kratom-Related Health Issues Raises Alarm Among Experts
3/27/2026, 12:41:28 AM
Rising Hospitalizations and Poison Center Calls
A recent study has revealed a dramatic increase in health issues associated with kratom, a natural supplement marketed for its energy-boosting, mood-lifting, and pain-relieving properties. Calls to poison centers regarding kratom have surged approximately 1,200% over the past decade, with hospitalizations rising from 43 in 2015 to 538 in 2025, marking an increase of over 1,150%. In 2025 alone, there were 3,434 reported exposures, a significant rise from just 258 a decade earlier. The majority of cases involved men in their 20s and 30s, although there has been a notable increase among individuals aged 40 to 59, indicating a broader demographic appeal.
Kratom, derived from the leaves of a tree native to Southeast Asia, contains psychoactive compounds mitragynine and 7-hydroxymitragynine (7-OH), which interact with the same brain receptors as opioids. At low doses, kratom acts as a stimulant, while at higher doses, it can produce sedative effects, including pain relief and euphoria. However, the substance has been linked to a range of adverse health effects, including nausea, vomiting, and more severe complications such as organ damage and psychosis, particularly when mixed with other substances.
Health Risks and Contamination Concerns
The unregulated nature of kratom products raises significant safety concerns, as they may contain harmful contaminants, including toxic metals and bacteria. Between 2015 and 2025, at least 233 deaths were associated with kratom, with 184 of those cases involving multiple substances. In 2025, 60% of hospitalizations related to kratom and other substances resulted in serious medical outcomes.
Dr. Chris Holstege, a researcher at the University of Virginia Health System, emphasized the alarming trend, stating, “We want the public to be aware that these products contain chemicals of varying concentrations that can cause drug interactions and adverse consequences in humans.”
Official Responses and Regulatory Actions
In response to the escalating health crisis, Health and Human Services Secretary Robert F. Kennedy Jr. announced intentions to push for stricter regulations on 7-OH products. The Food and Drug Administration (FDA) is advocating for 7-OH to be classified as a Schedule I substance, similar to heroin and LSD, due to its high potential for abuse. FDA Commissioner Marty Makary stated, “After the last wave of the opioid epidemic, we cannot get caught flat-footed again.”
Even the American Kratom Association, which has historically defended kratom, has expressed support for regulating chemically altered 7-OH products. Mac Haddow, a senior fellow on public policy at the organization, remarked, “These 7-OH products are not kratom. They are chemically altered substances with potent opioid-like effects that pose an imminent threat to consumers.”
Verbatim Quotes
- “The data reflects a concerning trend,” — Dr. Chris Holstege, University of Virginia Health System
- “7-OH is an opioid that can be more potent than morphine,” — FDA Commissioner Marty Makary
- “My family has experienced the unimaginable loss of our beloved daughter Emily,” — Austin Beutner, former Los Angeles mayoral candidate
Conclusion
The surge in kratom-related health issues underscores the urgent need for public awareness and regulatory action. As the debate over kratom's safety continues, health experts and officials are advocating for measures to mitigate the risks associated with its use.
